A large number of prestigious academic medical centers offer "executive screening" programs designed to allow asymptomatic people to obtain early risk assessment and detection of cardiovascular disease, presumably with the aim of earlier intervention and more favorable outcomes if an abnormality is identified. The problem is that indiscriminate screening is not only expensive but runs counter to evidence-based recommendations of medical societies for asymptomatic individuals without specific risk factors, say authors of a research letter published January13 in JAMA Internal Medicine. Continue reading →

A new review published in the Journal of the American College of Cardiology indicated that more than two million people with heart disease have used marijuana. Continue reading →

HOLLYWOOD, FLThe woeful lack of information on the safety and efficacy of peripheral vascular interventions in patients with cancer, as well as the complex interplay between the two diseases, underscores the need for dedicated care, one expert argued here at the 2020 International Symposium on Endovascular Therapy (ISET). To meet this need, Yolanda C. Bryce, MD (Memorial Sloan Kettering Cancer Center, New York, NY), spearheaded a unique noninvasive vascular imaging center at her hospital. Continue reading →

by Dr Fred Kniffin, former president of Porter Medical Center In late November, I was interviewed by a reporter who asked for my perspective regarding the topic of hospital consolidations, and to discuss some national studies that indicate that hospitals coming together means higher prices for patients. The reporter wanted to hear about Porters experience as an affiliate of the UVM Health Network since we joined the Network in early 2017 Continue reading →